
Jan 8 (Reuters) - Halozyme Therapeutics Inc HALO.O:
HALOZYME ANNOUNCES GLOBAL COLLABORATION AND LICENSE AGREEMENT WITH TAKEDA TO DEVELOP AND COMMERCIALIZE VEDOLIZUMAB WITH ENHANZE®
HALOZYME THERAPEUTICS INC - TAKEDA GAINS EXCLUSIVE ACCESS TO ENHANZE TECHNOLOGY
HALOZYME THERAPEUTICS INC - TAKEDA TO MAKE UPFRONT AND MILESTONE PAYMENTS TO HALOZYME
HALOZYME THERAPEUTICS INC - TO RECEIVE ROYALTIES ON VEDOLIZUMAB SALES